Are there any guidelines for splitting lipitor tablets?

Can Lipitor tablets be split safely?

Lipitor (atorvastatin) tablets carry a score line on many strengths, but the manufacturer does not recommend splitting them. The FDA-approved labeling states that the tablets should be swallowed whole unless a prescriber specifically instructs otherwise.

Why splitting is discouraged

Atorvastatin is not formulated as an extended-release product, yet uniform drug distribution within each tablet has not been verified for split portions. Uneven halves can produce dose variability that affects LDL reduction and side-effect risk. Pfizer’s prescribing information does not list tablet splitting as an approved administration method.

What the evidence shows

Small studies on statin splitting report acceptable average-content uniformity, but individual tablets can still deviate by more than 15 percent from the intended half-dose. Regulators therefore leave the decision to clinical judgment rather than endorsing routine splitting.

Alternatives when a lower dose is needed

Lower-strength tablets (10 mg, 20 mg) are widely available and usually cost the same or less per milligram than higher strengths, removing the economic incentive to split. Patients who still wish to split should use a calibrated tablet splitter and confirm the practice with their prescriber or pharmacist.

When does the Lipitor patent expire?

The composition-of-matter patent for atorvastatin expired in 2011; several generic versions now compete. No remaining patents block tablet splitting for cost savings, but formulation patents on certain generic atorvastatin products could affect scored versus unscored tablets.

DrugPatentWatch.com tracks current patent and exclusivity data for atorvastatin products and can be consulted for the latest legal-status updates.